Johnson and Johnson product liability claims are described in detail in the company's quarterly report filed with the SEC and released earlier this month. The company declines to put losses on its balance sheet "until a loss is determined to…
More than one million "adverse events" related to drugs were reported to the FDA in 2016. Among this overwhelming number, around 22,000 complaints concerned oral anticoagulants drugs like Xarelto, Eliquis, and other familiar brand names. Even more concerning is the…
The latest ad spot for Xarelto has all the hallmarks of a direct-to-consumer drug advertisement: cheery music, a story of redemption, and a mile-long list of side-effects rattled off as quickly as possible. This time, however, Xarelto's manufacturer Bayer and…
A new study examining the relative effectiveness of modern blood thinners finds that Xarelto is the most likely to cause gastrointestinal (GI) bleeding. Researchers at the mayo Clinic conducted a large population-based study on three popular anticoagulant brands: Eliquis, Pradaxa, and…
Most drugs are subject to varied press coverage over their lifetime. Blood-thinner Xarelto is no exception, as the latest research and legal challenges jockey for headline position as the year draws to a close. First, the good news... This week…
Oral anticoagulant Rivaroxaban, better known as Xarelto, has been at the center of numerous lawsuits due to a serious and dangerous side effect of uncontrollable bleeding. Xarelto is a blood thinner manufactured by Bayer and marketed by Johnson & Johnson’s subsidiary…
This is the original Xarelto commercial with Kevin Nealon and Brain Vickers, aired in 2015. While it lists several crucial side effects like bruising, nerve pain, and uncontrollable bleeding, the general air is that the drug provides liberation from the…